BioCryst Pharmaceuticals, Inc.
$9.82
-0.05 (-0.51%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +6.3%
- 3 Months
- +10.2%
- YTD
- +25.9%
- 1 Year
- +15.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 47.3%
- Largest decline max drawdown, since Aug 2025
- -27.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.53
Own BCRX?
See how BCRX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.